doi: 10.1212/01.WNL.0000163988.28892.79.
Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity
Affiliations
- PMID: 15955957
- DOI: 10.1212/01.WNL.0000163988.28892.79
Item in Clipboard
Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity
Neurology.
.
Abstract
We prospectively tested the quantitative myasthenia gravis score (QMG) for responsiveness and longitudinal construct validity in 53 patients with myasthenia gravis. Index of responsiveness was high. Longitudinal construct validity was confirmed by the correlation between changes in QMG and manual muscle testing and by a difference in QMG changes across patients that were clinically unchanged, improved, or worse between two visits. Our results support QMG use for assessing clinical change in trials.
Similar articles
-
Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.Clin Neurophysiol. 2007 Feb;118(2):269-77. doi: 10.1016/j.clinph.2006.10.004. Epub 2006 Dec 8. Clin Neurophysiol. 2007. PMID: 17157556
-
Treatment of ocular symptoms in myasthenia gravis.Neurology. 2008 Oct 21;71(17):1335-41. doi: 10.1212/01.wnl.0000327669.75695.38. Neurology. 2008. PMID: 18936425
-
[Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].Rinsho Shinkeigaku. 2007 Jun;47(6):356-8. Rinsho Shinkeigaku. 2007. PMID: 17633110 Japanese.
-
[Myasthenia gravis].Nihon Rinsho. 2005 May;63 Suppl 5:416-21. Nihon Rinsho. 2005. PMID: 15954385 Review. Japanese. No abstract available.
-
[Methods for diagnosing seronegative myasthenia gravis].Rev Neurol. 2008 Mar 16-31;46(6):360-4. Rev Neurol. 2008. PMID: 18368681 Review. Spanish.
Cited by
-
Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion.Neurol Sci. 2024 Dec;45(12):5671-5683. doi: 10.1007/s10072-024-07577-7. Epub 2024 Jul 5. Neurol Sci. 2024. PMID: 38967883 Review.
-
Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.J Clin Immunol. 2012 Oct;32(5):975-83. doi: 10.1007/s10875-012-9685-0. Epub 2012 Mar 31. J Clin Immunol. 2012. PMID: 22467037
-
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study.Front Pharmacol. 2022 Aug 16;13:982434. doi: 10.3389/fphar.2022.982434. eCollection 2022. Front Pharmacol. 2022. PMID: 36052140 Free PMC article.
-
Randomized Trial of Thymectomy in Myasthenia Gravis.N Engl J Med. 2016 Aug 11;375(6):511-22. doi: 10.1056/NEJMoa1602489. N Engl J Med. 2016. PMID: 27509100 Free PMC article. Clinical Trial.
-
Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control study.Front Neurol. 2023 Jan 11;13:1056322. doi: 10.3389/fneur.2022.1056322. eCollection 2022. Front Neurol. 2023. PMID: 36712429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
